1-8 of 8
Jack Mardekian
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Differences in Admission Rates Among Patients Treated with Apixaban Vs. Warfarin for Venous Thromboembolism in the Emergency Department

Steven Deitelzweig, MD, Patrick Hlavacek, MPH, Jack Mardekian, PhD, Lisa Rosenblatt, MD MPH, Cristina Russ, MD PhD, Kenneth Tuell, RPh, Melissa Lingohr-Smith, PhD, Jay Lin, PhD MBA, Jennifer D Guo, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2157.
https://doi.org/10.1182/blood-2019-125845
Published: 2019
Journal Articles

Safety and Effectiveness of Apixaban, LMWH, and Warfarin Among Venous Thromboembolism Patients with Active Cancer: A Retrospective Analysis Using Four US Claims Databases

Alexander T Cohen, MBBS, MSc, MD, Allison Keshishian, Theodore Lee, MD, Gail Wygant, RN, MS, Lisa Rosenblatt, MD MPH, Patrick Hlavacek, MPH, Jack Mardekian, PhD, Daniel Wiederkehr, MPH, Janvi Sah, MS, Xuemei Luo, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 326.
https://doi.org/10.1182/blood-2019-121769
Published: 2019
Journal Articles

Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale

Alexander T Cohen, MBBS, MSc, MD, Allison Keshishian, Theodore Lee, MD, Gail Wygant, RN, MS, Lisa Rosenblatt, MD MPH, Patrick Hlavacek, MPH, Jack Mardekian, PhD, Daniel Wiederkehr, MPH, Janvi Sah, MS, Xuemei Luo, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 327.
https://doi.org/10.1182/blood-2019-126931
Published: 2019
Journal Articles

Out-of-Pocket (OOP) Costs Associated with Tyrosine Kinase Inhibitors (TKIs) Used for the Treatment of US Patients Diagnosed with Chronic Myeloid Leukemia (CML): A US Retrospective Claims Analysis

Ruth Kim, Deepa Malhotra, Timothy Bell, Fiona An, MD, Jack Mardekian
Journal: Blood
Blood (2017) 130 (Supplement 1): 2123.
https://doi.org/10.1182/blood.V130.Suppl_1.2123.2123
Published: 2017
Journal Articles

Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

Amin N Alpesh, MBA, MD, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Kwanza Price, MPH, Lien Vo, MPH, PharmD, Prianka Singh, PharmD, Amanda Bruno, MPH, PhD, Jack Mardekian, PhD, Wilson Tan, MRCS, MD, Shalabh Singhal, MD, Chad Patel, PharmD, Kevin Odell, PharmD, Jeffrey Trocio, MPH
Journal: Blood
Blood (2015) 126 (23): 745.
https://doi.org/10.1182/blood.V126.23.745.745
Published: 2015
Journal Articles

Bleeding Incidence Among Patients With Venous Thromboembolism: A Large US Insurance Database Analysis

Xianchen Liu, MD, PhD, Lin Xie, MS, Hemant Phatak, PhD, Jack Mardekian, PhD, Wilson Tan, MD, Onur Baser, PhD, Eduardo Ramacciotti, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 2916.
https://doi.org/10.1182/blood.V122.21.2916.2916
Published: 2013
Journal Articles

Apixaban Reduces Hospitalization In Patients With Venous Thromboembolism: An Analysis Of The AMPLIFY-EXT Trial

Xianchen Liu, MD, PhD, John Thompson, PhD, Hemant Phatak, PhD, Jack Mardekian, PhD, Anthony R. Porcari, PhD, PharmD, Margot R. Johnson, MD, BSC
Journal: Blood
Blood (2013) 122 (21): 3638.
https://doi.org/10.1182/blood.V122.21.3638.3638
Published: 2013
Journal Articles

Health Care Resource Utilization and Cost in Patients with Chronic Myeloid Leukemia in a Privately Insured Patient Population in the United States,

Shrividya Iyer, PhD, Peter C Trask, PhD, MPH, Gordon Siu, MS, Jack Mardekian, PhD
Journal: Blood
Blood (2011) 118 (21): 4220.
https://doi.org/10.1182/blood.V118.21.4220.4220
Published: 2011